Amphastar Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03209R1032

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Shandell Jason B.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Shandell Jason B. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AMPH / Amphastar Pharmaceuticals, Inc. President and General Counsel, Director 179.276
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Shandell Jason B.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMPH / Amphastar Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insidersalg AMPH / Amphastar Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMPH / Amphastar Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2019-03-15 AMPH Shandell Jason B. 24.508 20,3379 24.508 20,3379 498.441 363 13.87 -158.515 -31,80
2017-05-31 AMPH Shandell Jason B. 3.654 17,2606 3.654 17,2606 63.070
2017-05-30 AMPH Shandell Jason B. 7.828 16,7642 7.828 16,7642 131.230

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMPH / Amphastar Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Shandell Jason B. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2020-03-18 2020-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -9.299 179.276 -4,93 14,50 -134.836 2.599.502
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 150.958 150.958
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 64.466 188.575 51,94
2020-03-18 2020-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -7.893 124.109 -5,98 13,03 -102.846 1.617.140
2020-03-17 2020-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -6.896 132.002 -4,96 14,19 -97.854 1.873.108
2020-02-07 2020-02-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -6.853 46.944 -12,74
2020-02-07 2020-02-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.853 138.898 -4,70 19,88 -136.260 2.761.737
2020-02-07 2020-02-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.853 145.751 4,93 14,40 98.683 2.098.814
2020-02-07 2020-02-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -21.933 53.797 -28,96
2020-02-07 2020-02-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -21.933 138.898 -13,64 19,83 -434.951 2.754.472
2020-02-07 2020-02-06 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 21.933 160.831 15,79 14,40 315.835 2.315.966
2020-02-07 2020-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -15.615 75.730 -17,09
2020-02-07 2020-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.615 138.898 -10,11 19,57 -305.554 2.717.956
2020-02-07 2020-02-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 15.615 154.513 11,24 14,40 224.856 2.224.987
2020-01-10 2020-01-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -25.000 9.149 -73,21
2020-01-10 2020-01-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -25.000 138.898 -15,25 18,44 -460.978 2.561.154
2020-01-10 2020-01-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 25.000 163.898 18,00 10,93 273.250 1.791.405
2019-12-20 2019-12-18 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -8.205 138.898 -5,58 19,13 -156.958 2.657.049
2019-09-20 2019-09-18 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.340 147.103 -4,75 21,32 -156.509 3.136.648
2019-07-12 2019-07-10 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -6.615 154.443 -4,11 20,31 -134.333 3.136.336
2019-05-02 2019-05-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -10.000 34.149 -22,65
2019-05-02 2019-05-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.000 159.947 -5,88 21,97 -219.700 3.514.036
2019-05-02 2019-05-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.000 169.947 6,25 10,93 109.300 1.857.521
2019-04-18 2019-04-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.478 159.947 -5,59 20,67 -195.879 3.305.577
2019-03-27 2019-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -6.603 169.425 -3,75 20,54 -135.626 3.479.990
2019-03-18 2019-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -9.876 176.028 -5,31 20,23 -199.791 3.561.046
2019-03-18 2019-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -8.381 185.904 -4,31 20,23 -169.548 3.760.838
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 86.862 86.862
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -24.508 44.149 -35,70
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -5.255 194.285 -2,63 20,23 -106.309 3.930.386
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 39.050 199.540 24,33
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -24.508 160.490 -13,25 20,34 -498.441 3.264.030
2019-03-18 2019-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 24.508 184.998 15,27 10,93 267.872 2.022.028
2019-03-18 2019-03-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.828 160.490 -4,65 20,37 -159.489 3.269.855
2019-03-01 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.500 0 -100,00
2019-03-01 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.500 168.318 -4,27 24,99 -187.425 4.206.267
2019-03-01 2019-03-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.500 175.818 4,46 20,26 151.950 3.562.073
2019-02-15 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -7.519 0 -100,00
2019-02-15 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.519 168.318 -4,28 23,99 -180.381 4.037.949
2019-02-15 2019-02-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise -7.519 175.837 -4,10 15,23 -114.514 2.677.998
2019-01-25 2019-01-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -200 168.318 -0,12 22,95 -4.590 3.862.898
2019-01-25 2019-01-23 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.297 168.518 -8,32 22,39 -342.429 3.772.343
2018-12-06 2018-12-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -16.630 0 -100,00
2018-12-06 2018-12-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -16.630 183.815 -8,30 22,44 -373.177 4.124.809
2018-12-06 2018-12-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 16.630 200.445 9,05 10,48 174.282 2.100.664
2018-11-15 2018-11-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -400 183.490 -0,22 20,19 -8.076 3.704.663
2018-11-15 2018-11-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -15.615 183.890 -7,83 20,41 -318.779 3.754.096
2018-11-09 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -16.095 0 -100,00
2018-11-09 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -16.095 199.505 -7,47 20,99 -337.834 4.187.610
2018-11-09 2018-11-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 16.095 215.600 8,07 10,46 168.354 2.255.176
2018-11-09 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -30.901 16.095 -65,75
2018-11-09 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -5.300 0 -100,00
2018-11-09 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -36.201 199.505 -15,36 20,68 -748.586 4.125.484
2018-11-09 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 30.901 235.706 15,09 10,46 323.224 2.465.485
2018-11-09 2018-11-08 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.300 204.805 2,66 11,79 62.487 2.414.651
2018-07-12 2018-07-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -14.399 199.505 -6,73 16,77 -241.422 3.345.021
2018-03-28 2018-03-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -7.833 212.561 -3,55 18,47 -144.676 3.926.002
2018-03-28 2018-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -4.492 220.394 -2,00 18,61 -83.596 4.101.532
2018-03-20 2018-03-20 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -8.293 224.886 -3,56 19,52 -161.871 4.389.550
2018-03-20 2018-03-19 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -11.707 233.179 -4,78 19,37 -226.767 4.516.724
2018-03-20 2018-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -6.486 244.886 -2,58 19,91 -129.136 4.875.680
2018-03-20 2018-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -5.495 251.372 -2,14 19,91 -109.405 5.004.817
2018-03-16 2018-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 92.692 92.692
2018-03-16 2018-03-15 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 39.919 256.867 18,40
2018-03-15 2018-03-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -400 5.300 -7,02
2018-03-15 2018-03-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -400 216.948 -0,18 20,45 -8.180 4.436.587
2018-03-15 2018-03-14 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 400 217.348 0,18 11,79 4.716 2.562.533
2018-03-15 2018-03-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -300 5.700 -5,00
2018-03-15 2018-03-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -300 216.948 -0,14 20,45 -6.135 4.436.587
2018-03-15 2018-03-13 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 300 217.248 0,14 11,79 3.537 2.561.354
2018-01-26 2018-01-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.966 216.948 -4,39 19,56 -194.925 4.243.286
2018-01-26 2018-01-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -8.661 226.914 -3,68 19,26 -166.822 4.370.659
2017-07-07 2017-07-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -3.394 235.493 -1,42 17,95 -60.922 4.227.099
2017-06-01 2017-05-31 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -3.654 237.688 -1,51 17,26 -63.070 4.102.637
2017-06-01 2017-05-30 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale -7.828 241.342 -3,14 16,76 -131.230 4.045.906
2017-03-28 2017-03-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -5.938 249.170 -2,33 14,27 -84.735 3.555.656
2017-03-28 2017-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -4.714 255.108 -1,81 13,76 -64.865 3.510.286
2017-03-20 2017-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -7.049 259.822 -2,64 13,75 -96.924 3.572.552
2017-03-20 2017-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 158.784 158.784
2017-03-20 2017-03-16 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 63.670 266.871 31,33
2016-11-29 2016-11-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -24.292 68.657 -26,13
2016-11-29 2016-11-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -24.292 202.961 -10,69 20,47 -497.201 4.154.145
2016-11-29 2016-11-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 24.292 227.253 11,97 10,93 265.512 2.483.875
2016-11-29 2016-11-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -2.043 92.949 -2,15
2016-11-29 2016-11-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.043 202.961 -1,00 20,59 -42.057 4.178.115
2016-11-29 2016-11-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 2.043 205.004 1,01 10,93 22.330 2.240.694
2016-09-27 2016-09-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -56.996 94.992 -37,50
2016-09-27 2016-09-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -56.996 202.961 -21,93 19,50 -1.111.268 3.957.192
2016-09-27 2016-09-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 56.996 259.957 28,08 10,93 622.966 2.841.330
2016-08-24 2016-08-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -10.000 46.996 -17,55
2016-08-24 2016-08-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -10.000 202.961 -4,70 19,95 -199.500 4.049.072
2016-08-24 2016-08-22 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
M - Exercise 10.000 212.961 4,93 10,46 104.600 2.227.572
2016-08-19 2016-08-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.987 202.961 -2,87 18,86 -112.909 3.827.641
2016-08-15 2016-08-11 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.636 208.948 -2,63 18,01 -101.482 3.762.339
2016-07-07 2016-07-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -3.394 214.584 -1,56 16,33 -55.424 3.504.157
2016-06-13 2016-06-09 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.904 216.610 -4,37 16,43 -162.723 3.558.902
2016-05-26 2016-05-25 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.074 226.514 -0,47 15,60 -16.754 3.533.618
2016-03-29 2016-03-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -5.938 227.588 -2,54 11,96 -71.018 2.721.952
2016-03-29 2016-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -4.714 233.526 -1,98 11,96 -56.379 2.792.971
2016-03-21 2016-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 225.153 225.153
2016-03-21 2016-03-17 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 75.022 238.240 45,96
2016-02-03 3/A AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
3.332
2015-10-06 2015-10-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -987 159.030 -0,62 11,69 -11.538 1.859.061
2015-09-30 2015-09-28 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -770 160.017 -0,48 10,97 -8.447 1.755.386
2015-07-07 2015-07-05 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -3.394 160.787 -2,07 17,24 -58.513 2.771.968
2015-07-07 2015-03-27 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -5.895 164.181 -3,47 15,43 -90.960 2.533.313
2015-03-30 2015-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
A - Award 150.183 150.183
2015-03-30 2015-03-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
A - Award 50.167 170.076 41,84
2015-03-30 2014-10-03 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -988 119.909 -0,82 11,41 -11.273 1.368.162
2015-03-30 2014-09-26 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -770 120.897 -0,63 11,83 -9.109 1.430.212
2015-03-30 2014-08-01 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -1.352 121.667 -1,10 8,84 -11.952 1.075.536
2015-03-30 2014-07-07 4 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
F - Taxes -4.413 123.019 -3,46 8,75 -38.614 1.076.416
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
145.534
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
128.098
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
131.527
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
132.685
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
163.553
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
190.627
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
145.534
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
128.098
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
131.527
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
132.685
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
163.553
2014-06-24 3 AMPH Amphastar Pharmaceuticals, Inc.
Common Stock
190.627
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)